Copaxone Injection, Solution
Product Images NDC 68546-317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Copaxone (NDC 68546-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Neuroscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image01 (Image 1)

Image01 (Image 1)
FDA Label Image

Figure G (Image 10)

Figure G (Image 10)
FDA Label Image

Figure H (Image 11)

Figure H (Image 11)
FDA Label Image

Figure I (Image 12)

Figure I (Image 12)
FDA Label Image

Figure J (Image 13)

Figure J (Image 13)
FDA Label Image

Figure K (Image 14)

Figure K (Image 14)
FDA Label Image

Figure L (Image 15)

Figure L (Image 15)
FDA Label Image

Logo (Image 16)

Logo (Image 16)
FDA Label Image

20mg Carton (Image 17)

20mg Carton (Image 17)
FDA Label Image

40mg Carton (Image 18)

40mg Carton (Image 18)
FDA Label Image

Image02 (Image 2)

Image02 (Image 2)
FDA Label Image

Logo (Image 3)

Logo (Image 3)
FDA Label Image

Figure A (Image 4)

Figure A (Image 4)
The text is providing two distinct phrases: "Sharps Disposal Container" and "Cotton Balls". These phrases may imply the presence or use of containers specifically designed for the safe disposal of sharp objects, such as needles, and the use of cotton balls for medical or cosmetic purposes. It is unclear whether these two phrases are related or represent separate topics.*
FDA Label Image

Figure B (Image 5)

Figure B (Image 5)
FDA Label Image

Figure C (Image 6)

Figure C (Image 6)
This appears to be a set of instructions for avoiding certain areas while administering a procedure, possibly a medical or cosmetic treatment. It includes specific instructions for avoiding the belly button area, fleshy areas of the hips and upper back portion of the arms, and certain areas of the thighs when treating them.*
FDA Label Image

Figure D (Image 7)

Figure D (Image 7)
FDA Label Image

Figure E (Image 8)

Figure E (Image 8)
FDA Label Image

Figure F (Image 9)

Figure F (Image 9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.